Previous close | 2.4820 |
Open | 2.4880 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.4700 - 2.5030 |
52-week range | 1.4892 - 2.6200 |
Volume | |
Avg. volume | 10 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, June 28, 2024--Barclays PLC notes the Federal Reserve Board’s ("FRB") publication of the results from its annual bank stress tests on 26 June 2024. The projected capital ratios for Barclays US LLC (Barclays’ US intermediate holding company) remained above the regulatory minimum required levels across all nine quarters of the test.
NEW YORK, June 14, 2024--Barclays Bank PLC ("Barclays") announced today that it will exercise its issuer call option and redeem in full each of the 18 series of iPath® ETNs (the "ETNs") listed in the table below on June 28, 2024 (the "Redemption Date").
NEW YORK, June 05, 2024--Barclays Bank PLC (the "Issuer") announced today that, in connection with its previously announced cash tender offers (each, an "Offer") to purchase any and all of its outstanding exchange-traded notes (the "Notes" or the "ETNs") of the thirteen separate series listed in tables below (each, a "Series") and the solicitation of consents (each, a "Consent Solicitation") from holders of the Notes (the "Noteholders") to amend certain provisions of the Notes with respect to ea